The Global Pharmaceuticals sector witnessed 28 Equity Offering deals in July 2022, for an aggregate deal value of $1,890.0 million. This represents a decrease of 6.7% in terms of value and a decrease of 17.0% in terms of volume, year over year.
A total of 413 Equity Offering deals were recorded over the last twelve months (LTM) for an aggregate deal value of $30,998.6 million. In the LTM period, November 2021, turned out to be the most prolific in terms of deal size, with a total deal value of $191.0 million and a deal volume of 3 during that month. On the other hand, the month of November 2021, was the most prolific in terms of deal volume, recording a total of 49 deals with a total deal value of $7,075.3 million during that month.
On an average, over the LTM period, 34 deals were done with an average deal size of $2,583.2 million.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward